Open Access:
A stated preference survey to explore patient preferences for novel preventive #migraine treatments
L Hubig, @timsmithmd@ginniechua A Lloyd, L Powell, K Johnston, L Harris, G L'Italien, V Coric, @SiuHingLo
https://t.co/MGwM0q6pGe
#neurotwitter
BREAKING: Students, faculty and staff on WashU's campus were told to hide and barricade themselves in a room until further notice. https://t.co/Ae91tZ89A1
Living w/#headache, #migraine & #clusterdisease can feel isolating. CHAMP members have created several online communities so that you can communicate with others that have experienced — and overcome — insurance access issues. Learn more: https://t.co/crlN9gFVno
Did you know that what we eat can affect the level of inflammation in our body? Check out this article to learn about some of the common offenders. https://t.co/F4QIS649Ta
After decades of advocacy, education and research, the number and quality of new treatments and prevention methods available and currently in-research has reached a new peak. #headache#migraine#research
Read more: https://t.co/Igze6g6uZX
As an officer of the National Headache Foundation, I was dismayed by reports of unfair insurance restrictions on reimbursement for the new CGRP antibody for refractory migraine, erenumab. Sharing my NHF blog on the topic here. https://t.co/vLowVkeost
"Some #Insurance Companies may be Placing Unfair Restrictions on Access to New #Migraine Prevention Treatments" by Dr. Timothy Smith: #NotAlone#NHF
https://t.co/FrYR75Lc6X
The National Headache Foundation has begun to conduct surveys with thousands of our patient members on important topics. The results are accumulating and we are beginning to analyze some of the data. #headache#migraine#meaningfulrelief#NHF https://t.co/RVnh2ZJRa0
#Migraine is a debilitating disease that impacts over 37 million people in the United States. While unfortunate, those who suffer from regular migraines have a higher risk of developing other health issues, such as anxiety, depression and more. https://t.co/dmDcR4Yg2i
At 1 p.m. PST on June 13, #migraine patients will give their perspective on ICER's review of new migraine therapies prior to the public ICER meeting on June 14. You'll be able to watch, participate and ask questions directly from Facebook Live. #headache
https://t.co/18ThGQQnVo
RT @shades4migraine: Don't forget to help spread the #shadesformigraine message by signing up with our Thunderclap! We've already created the message for you, all you have to do is help spread it!
For more info and to sign up: https://t.co/yVRC2oYwp9